Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14194004 | 0.82 | TSHR (0.37) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL6654333 | 0.80 | TSHR (0.40) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL476966 | 0.78 | TSHR (0.61) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL12547083 | 0.77 | TSHR (0.60) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL4596157 | 0.75 | TSHR (0.69) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL3293446 | 0.75 | TSHR (0.63) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL553911 | 0.75 | — | — | |
| SCHEMBL6648347 | 0.74 | — | — | |
| SCHEMBL30583614 | 0.74 | TSHR (0.48) | TSHRALDH1A1HPGDTP53HIF1A | |
| SCHEMBL27342790 | 0.74 | TSHR (0.43) | TSHRALDH1A1HPGDTP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140445-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CANON KK (JP) | 2026-05-21 | — | — | US | disclosed |
| US-20260126725-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CANON KK (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4738008-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | Canon Kabushiki Kaisha (JP) | 2026-05-06 | — | — | EP | disclosed |
| CN-119596642-A | Curable composition, film forming method and manufacturing method | 佳能株式会社 | 2025-03-11 | — | — | CN | disclosed |
| CN-119343746-A | Curable composition, reverse pattern forming method, film forming method, and article manufacturing method | 佳能株式会社 | 2025-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260126725-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | ATM, ATR, PIEZO1 | TSHR 4373/4885ALDH1A1 3970/4885HPGD 4515/4885 |
| US-20260140445-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CFL1, ATM, PSPC1 | TSHR 3425/4885ALDH1A1 3881/4885HPGD 4769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.